Literature DB >> 12525268

Targeted topical peripheral analgesics in the management of pain.

Charles E Argoff1.   

Abstract

The term "targeted peripheral analgesics" has been developed to describe analgesics whose mechanism of action appears to be primarily through reducing pain transmission within the peripheral nervous system. Key differences between targeted peripheral and systemic analgesics and the difference between topical and transdermal analgesics are discussed. A review of the clinical conditions that have reportedly responded to targeted peripheral analgesics is described in detail in this article.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525268     DOI: 10.1007/s11916-003-0007-3

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  27 in total

1.  Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.

Authors:  Arnold R Gammaitoni; Matthew W Davis
Journal:  Ann Pharmacother       Date:  2002-02       Impact factor: 3.154

2.  Use of EMLA cream in the treatment of post-herpetic neuralgia.

Authors:  S J Litman; S A Vitkun; P J Poppers
Journal:  J Clin Anesth       Date:  1996-02       Impact factor: 9.452

Review 3.  The mechanisms of action of NSAIDs in analgesia.

Authors:  J N Cashman
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study.

Authors:  G McCleane
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

5.  Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomised, double-blind, placebo-controlled study.

Authors:  J Machen; M Whitefield
Journal:  Int J Clin Pract       Date:  2002-03       Impact factor: 2.503

6.  Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study.

Authors:  A Devers; B S Galer
Journal:  Clin J Pain       Date:  2000-09       Impact factor: 3.442

7.  Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains.

Authors:  J Campbell; T Dunn
Journal:  J Accid Emerg Med       Date:  1994-09

8.  Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia.

Authors:  Michael C Rowbotham; Pamela S Davies; Christina Verkempinck; Bradley S Galer
Journal:  Pain       Date:  1996-04       Impact factor: 6.961

9.  DHEP plasters as a topical treatment of knee osteoarthritis--a double-blind placebo-controlled study.

Authors:  R L Dreiser; M Tisne-Camus
Journal:  Drugs Exp Clin Res       Date:  1993

10.  A trial with diclofenac HEP plaster as topical treatment in minor sport injuries.

Authors:  P Jenoure; B Segesser; U Lühti; G Gremion
Journal:  Drugs Exp Clin Res       Date:  1993
View more
  6 in total

Review 1.  Targeted peripheral analgesics therapy for neuropathic pain.

Authors:  Charles E Argoff
Journal:  Curr Pain Headache Rep       Date:  2004-06

Review 2.  Topical treatments for pain.

Authors:  Charles E Argoff
Journal:  Curr Pain Headache Rep       Date:  2004-08

Review 3.  Topical agents for the treatment of chronic pain.

Authors:  Charles E Argoff
Journal:  Curr Pain Headache Rep       Date:  2006-02

4.  Skin Matters: A Review of Topical Treatments for Chronic Pain. Part One: Skin Physiology and Delivery Systems.

Authors:  John F Peppin; Phillip J Albrecht; Charles Argoff; Burkhard Gustorff; Marco Pappagallo; Frank L Rice; Mark S Wallace
Journal:  Pain Ther       Date:  2015-01-28

5.  Efficacy and safety of 5% lidocaine patches for postoperative pain management in patients undergoing unilateral inguinal hernia repair: study protocol for a prospective, double-blind, randomized, controlled clinical trial.

Authors:  Hong-Min Ahn; Heung-Kwon Oh; Duck-Woo Kim; Sung-Bum Kang; Bon-Wook Koo; Pyung-Bok Lee
Journal:  Trials       Date:  2022-09-11       Impact factor: 2.728

6.  Human keratinocytes are vanilloid resistant.

Authors:  László Pecze; Kornélia Szabó; Márta Széll; Katalin Jósvay; Krisztián Kaszás; Erzsébet Kúsz; Tamás Letoha; János Prorok; István Koncz; András Tóth; Lajos Kemény; Csaba Vizler; Zoltán Oláh
Journal:  PLoS One       Date:  2008-10-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.